Arnaud, Alix http://orcid.org/0000-0003-1193-4258
Suthoff, Ellison
Tavares, Rita M.
Zhang, Xuan
Ravindranath, Aditi J.
Funding for this research was provided by:
Sage Therapeutics
Article History
Accepted: 16 March 2021
First Online: 28 April 2021
Declarations
:
: This study was funded by Sage Therapeutics, Inc. and completed by Boston Strategic Partners (supported by Sage Therapeutics, Inc.).
: Alix Arnaud and Ellison Suthoff are employees of Sage Therapeutics, Inc. with stock/stock options. Rita M. Tavares, Xuan Zhang and Aditi J. Ravindranath declare no competing interests.
: Not applicable.
: Not applicable.
: Not applicable.
: The data that support the findings of this study are available from Truven Health Analytics MarketScan<sup>®</sup>, but restrictions apply to the availability of these data, which were used under license for the current study and so are not publicly available.
: Custom code can be made available from authors upon reasonable request.
: All authors contributed to the study conception and design. Analyses were performed by RMT, XZ, and AJR. The first draft of the manuscript was written by AJR, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.